Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Use of Jumonji C demethylase inhibitors for the treatment and prevention of chemotherapy resistance and radioresistance in cancer

Use of Jumonji C demethylase inhibitors for the treatment and prevention of chemotherapy resistance and radioresistance in cancer

US Patent 11497740 · Granted Nov 15, 2022

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Macrocyclic compounds as sting agonists and methods and uses thereof2025
Compositions and methods of targeting cancer stem cells2024
Compositions and methods of targeting cancer stem cells2023
Sulfonamide compounds as voltage-gated sodium channel modulators2019
Chromosome 3p21.3 genes are tumor suppressors2018
Antiviral compounds with a heterotricycle moiety2015
Antiviral compounds with a dibenzooxaheterocycle moiety2015
Modulation of gene expression by oligomers targeted to chromosomal DNA2012
Chromosome 3p21.3 genes are tumor suppressors2011
Chromosome 3p21.3 genes are tumor suppressors2011
Interfering RNAs against the promoter region of P532010
SEMA3B inhibits tumor growth and induces apoptosis in cancer cells2010